Invitae (NYSA:NVTA)

Clinical genetic tests for hereditary disorders, including oncology (including BRCA1/BRCA2 for breast cancer), cardiology, neurology and pediatric med....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Invitae (NYSA:NVTA) plus 5959 other startups.

Learn More About Invitae (NYSA:NVTA)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More